相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy
Ruijuan Du et al.
MOLECULAR CANCER (2021)
A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma
Belamy B. Cheung et al.
ONCOGENE (2021)
An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability
Zsuzsanna Nagy et al.
NATURE COMMUNICATIONS (2021)
Analysis of physicochemical properties of protein-protein interaction modulators suggests stronger alignment with the rule of five
Jia Truong et al.
RSC MEDICINAL CHEMISTRY (2021)
Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding Interface
Jessica Koach et al.
CANCER RESEARCH (2019)
N-Myc mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer
Adeline Berger et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Proteome-wide identification of ubiquitin interactions using UbIA-MS
Xiaofei Zhang et al.
NATURE PROTOCOLS (2018)
The Expanding World of N-MYC-Driven Tumors
David S. Rickman et al.
CANCER DISCOVERY (2018)
The role of GATA2 in lethal prostate cancer aggressiveness
Veronica Rodriguez-Bravo et al.
NATURE REVIEWS UROLOGY (2017)
Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries
Valentina Boeva et al.
NATURE GENETICS (2017)
Computational analysis of calculated physicochemical and ADMET properties of protein-protein interaction inhibitors
David Lagorce et al.
SCIENTIFIC REPORTS (2017)
A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer
Daniel Dauch et al.
NATURE MEDICINE (2016)
A Targetable GATA2-IGF2 Axis Confers Aggressiveness in Lethal Prostate Cancer
Samuel J. Vidal et al.
CANCER CELL (2015)
The history and future of targeting cyclin-dependent kinases in cancer therapy
Uzma Asghar et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma
Daniel R. Carter et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Oncogenic protein interfaces: small molecules, big challenges
Tracy L. Nero et al.
NATURE REVIEWS CANCER (2014)
Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma
Markus Brockmann et al.
CANCER CELL (2013)
Method for estimating the single molecular affinity
Richard B. M. Schasfoort et al.
ANALYTICAL BIOCHEMISTRY (2012)
DAVID-WS: a stateful web service to facilitate gene/protein list analysis
Xiaoli Jiao et al.
BIOINFORMATICS (2012)
Role of down-regulated neutral ceramidase during all-trans retinoic acid-induced neuronal differentiation in SH-SY5Y neuroblastoma cells
Kouji Tanaka et al.
JOURNAL OF BIOCHEMISTRY (2012)
Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency
Rachel Emma Dickinson et al.
BLOOD (2011)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
FRED Pose Prediction and Virtual Screening Accuracy
Mark McGann
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)
Pia Ostergaard et al.
NATURE GENETICS (2011)
Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian Cancers
Aslaug Helland et al.
PLOS ONE (2011)
SIRT1 Promotes N-Myc Oncogenesis through a Positive Feedback Loop Involving the Effects of MKP3 and ERK on N-Myc Protein Stability
Glenn M. Marshall et al.
PLOS GENETICS (2011)
Mass Spectrometry-Based Label-Free Quantitative Proteomics
Wenhong Zhu et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Medical Progress: Recent Advances in Neuroblastoma.
John M. Maris
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Myc proteins as therapeutic targets
W. C. Gustafson et al.
ONCOGENE (2010)
Cholinergic switch associated with morphological differentiation in neuroblastoma
Franck Bourdeaut et al.
JOURNAL OF PATHOLOGY (2009)
Global Identification of Myc Target Genes Reveals Its Direct Role in Mitochondrial Biogenesis and Its E-Box Usage In Vivo
Jonghwan Kim et al.
PLOS ONE (2008)
The influence of drug-like concepts on decision-making in medicinal chemistry
Paul D. Leeson et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
The crystal structure of Ebp1 reveals a methionine aminopeptidase fold as binding platform for multiple interactions
Eva Kowalinski et al.
FEBS LETTERS (2007)
Comparison of shape-matching and docking as virtual screening tools
Paul C. D. Hawkins et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Gaussian docking functions
MR McGann et al.
BIOPOLYMERS (2003)
分享论文
